Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer.
作者： H S Parra , R Cavina , F Latteri , P A Zucali , E Campagnoli
关键词:
摘要: Analysis of epidermal growth factor receptor expression as a predictive for response to gefitinib (‘Iressa’, ZD1839) in non-small-cell lung cancer
nature.com
elsevier.com
sci-hub.se 参考文章(20)
Frank V. Fossella, Russell DeVore, Ronald N. Kerr, Jeffrey Crawford, Ronald R. Natale, Frank Dunphy, Leonard Kalman, Vincent Miller, Jin Soo Lee, Melvin Moore, David Gandara, Daniel Karp, Everett Vokes, Mark Kris, Yong Kim, Francis Gamza, Luz Hammershaimb, , Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens Journal of Clinical Oncology. ,vol. 18, pp. 2354- 2362 ,(2000) , 10.1200/JCO.2000.18.12.2354
M Paesmans, J P Sculier, P Libert, G Bureau, G Dabouis, J Thiriaux, J Michel, O Van Cutsem, R Sergysels, P Mommen, Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. Journal of Clinical Oncology. ,vol. 13, pp. 1221- 1230 ,(1995) , 10.1200/JCO.1995.13.5.1221
Yosef Yarden, Mark X. Sliwkowski, Untangling the ErbB signalling network Nature Reviews Molecular Cell Biology. ,vol. 2, pp. 127- 137 ,(2001) , 10.1038/35052073
Y Ohsaki, S Tanno, Y Fujita, E Toyoshima, S Fujiuchi, Y Nishigaki, S Ishida, A Nagase, N Miyokawa, S Hirata, K Kikuchi, Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncology Reports. ,vol. 7, pp. 603- 610 ,(2000) , 10.3892/OR.7.3.603
Stephanie Green, Geoffrey R. Weiss, Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Investigational New Drugs. ,vol. 10, pp. 239- 253 ,(1992) , 10.1007/BF00944177
Nagio Takigawa, Yoshihiko Segawa, Masayuki Okahara, Yoshinobu Maeda, Ichiro Takata, Masaaki Kataoka, Masafumi Fujii, Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation. Lung Cancer. ,vol. 15, pp. 67- 77 ,(1996) , 10.1016/0169-5002(96)00571-5
M Volm, W Rittgen, P Drings, Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. British Journal of Cancer. ,vol. 77, pp. 663- 669 ,(1998) , 10.1038/BJC.1998.106
Herbert Biggs, A Decade of Progress Australian Journal of Rehabilitation Counselling. ,vol. 10, ,(2004) , 10.1017/S1323892200000211
Wilbur A Franklin, Robert Veve, Fred R Hirsch, Barbara A Helfrich, Paul A Bunn, Epidermal growth factor receptor family in lung cancer and premalignancy. Seminars in Oncology. ,vol. 29, pp. 3- 14 ,(2002) , 10.1053/SONC.2002.31520
R.I Nicholson, J.M.W Gee, M.E Harper, EGFR and cancer prognosis. European Journal of Cancer. ,vol. 37, pp. 9- 15 ,(2001) , 10.1016/S0959-8049(01)00231-3